SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950115-00-001068
Filing Date
2000-09-07
Accepted
2000-09-07 00:00:00
Documents
4
Period of Report
2000-08-29
Items
Item 5: Other events
Item 7: Financial statements and exhibits

Document Format Files

Seq Description Document Type Size
1 REGISTRATION STATEMENT 0001.txt 8-K 5205
2 COMMON STOCK PURCHASE AGREEMENT 0002.txt EX-99.1 84432
3 REGISTRATION RIGHTS AGREEMENT 0003.txt EX-99.2 38746
4 STOCK PURCHASE WARRANT 0004.txt EX-99.3 30262
  Complete submission text file 0000950115-00-001068.txt   160632
Mailing Address 33 HARBOUR SQ STE 202 TORONTO ONTARIO M5J A1
Business Address 33 HARBOUR SQ STE 202 TORONTO ONTARIO CANA A1 4163642551
GENEREX BIOTECHNOLOGY CORP (Filer) CIK: 0001059784 (see all company filings)

IRS No.: 820490211 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-25169 | Film No.: 718308
SIC: 2834 Pharmaceutical Preparations